Sanofi is looking at new compounds to expand MS business

Aubagio is an oral treatment approved for MS.

Sanofi is looking at new compounds to expand MS business

Postby MSUK » Wed Apr 25, 2012 12:02 am

Image

Sanofi, which bought Genzyme Corp. last year, is seeking new treatments to expand its multiple sclerosis business, said Michael Panzara, Genzyme’s therapeutic area head for multiple sclerosis, immune diseases and neurology.

The drugmaker said today its experimental medicine Lemtrada, which it gained through Genzyme, led to an improvement in disability scores in patients suffering from multiple sclerosis compared with an older treatment in a late-stage trial. The company has another experimental MS therapy, Aubagio, which was under development before the Genzyme purchase.

Beyond Lemtrada and Aubagio, Paris-based Sanofi has other experimental MS compounds in its pipeline “that we are actively starting to look at, and we’re always looking externally for good opportunities,” Panzara said in a phone interview today.....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2479
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2092
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Aubagio (teriflunomide)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users